Literature DB >> 29239004

Providing Comprehensive Medication Management in Telehealth.

Melissa E Badowski1, Scot Walker1, Shaffeeulah Bacchus1, Sandy Bartlett1, Juliana Chan1, Kelly A Cochran1, Scott Coon1, Michelle Liedtke1, Bradley G Phillips1, Taylor White1.   

Abstract

The goal of this white paper is to provide direction for clinical pharmacists providing telehealth. Telehealth care is rapidly emerging to improve patient access to health care and optimize patient health outcomes. With the increasing ability to access electronic health record portals, as many as 75 million telehealth encounters are expected in North America annually. Although electronic "point of access" undoubtedly increases the use of medical and pharmacy services, the real value of telehealth lies in improved access to patients in remote areas lacking adequate medical and pharmacy services and to high-risk patients requiring frequent monitoring. This document is intended to serve as a guide for those interested in or already using telehealth to provide direct patient care. Specifically, it focuses on general concepts of telehealth and demonstrates how the delivery of comprehensive medication management (CMM) by telehealth aligns with the Standards of Practice for Clinical Pharmacists set forth by the American College of Clinical Pharmacy. Although clinical pharmacists must be appropriately credentialed and privileged to provide CMM, their process of care must also be adapted to suit the remote patient. Patient assessment, evaluation of medication therapy, development and implementation of a plan of care, follow-up, monitoring, and documentation of all processes of care are influenced by the technology available, the collaborations established, and the applicable regulations and requirements for telehealth practice.
© 2017 Pharmacotherapy Publications, Inc.

Entities:  

Keywords:  clinical pharmacist; clinical pharmacy; collaborative drug therapy management; comprehensive medication management; direct patient care; technology; telehealth

Mesh:

Year:  2018        PMID: 29239004     DOI: 10.1002/phar.2071

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  5 in total

1.  Report of the 2017-2018 Strategic Engagement Standing Committee.

Authors:  Gina D Moore; Vibhuti Arya; Elias B Chahine; Diane B Ginsburg; Karl M Hess; Pamela M Moye; Patrick Nelson; Jeffrey O Ekoma
Journal:  Am J Pharm Educ       Date:  2018-09       Impact factor: 2.047

2.  Incorporation of an Efficient Pharmacist Workflow During the Transition From In-Person to Telemedicine Geriatric Clinics in Response to the COVID-19 Pandemic.

Authors:  Jeffrey C Reist; Brent Zahn; Onyeche Oche; Zacariah K Shannon; Carri Casteel; Richard C Dobyns; Korey A Kennelty
Journal:  J Pharm Pract       Date:  2022-07-03

3.  Exploring the perception and readiness of Pharmacists towards telepharmacy implementation; a cross sectional analysis.

Authors:  Khayal Muhammad; Mohamed A Baraka; Syed Sikandar Shah; Muhammad Hammad Butt; Haytham Wali; Muhammad Saqlain; Tauqeer Hussain Mallhi; Khezar Hayat; Khairi Mustafa Fahelelbom; Royes Joseph; Yusra Habib Khan
Journal:  PeerJ       Date:  2022-05-25       Impact factor: 3.061

4.  Creating a Pharmacotherapy Collaborative Practice Network to Manage Medications for Children and Youth: A Population Health Perspective.

Authors:  Richard H Parrish II; Danielle Casher; Johannes van den Anker; Sandra Benavides
Journal:  Children (Basel)       Date:  2019-04-09

5.  Evaluating the primary care clinical pharmacist visit transition to telehealth during the COVID-19 pandemic by comparing medication related problems from telehealth visits and in-person visits.

Authors:  Anusha McNamara; Milly Zhao; Shin-Yu Lee
Journal:  J Am Coll Clin Pharm       Date:  2021-06-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.